Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $636,276 (100.0% shares, 0.0% debt)

Holdings (46)

APLS APELLIS PHARMACEUTICALS INC 17.4%
Value ($000) $110,511 Shares 2,880,880 Est. Cost $47.53 Unrealized -4.7%
DNTH DIANTHUS THERAPEUTICS INC 7.1%
Value ($000) $45,204 Shares 1,746,667 Est. Cost $19.26 Unrealized +24.8%
GPCR STRUCTURE THERAPEUTICS INC 7.0%
Value ($000) $44,770 Shares 1,140,060 Est. Cost $40.10 Unrealized —
INSM INSMED INC 6.8%
Value ($000) $43,564 Shares 650,216 Est. Cost $21.76 Unrealized +78.3%
DYN DYNE THERAPEUTICS INC 6.5%
Value ($000) $41,670 Shares 1,180,798 Est. Cost $16.21 Unrealized +79.2%
AVBP ARRIVENT BIOPHARMA INC 5.3%
Value ($000) $33,451 Shares 1,803,304 Est. Cost $20.17 Unrealized -11.6%
— VERONA PHARMA PLC 4.3%
Value ($000) $27,405 Shares 1,895,200 Est. Cost $17.59 Unrealized —
CRBP CORBUS PHARMACEUTICALS HLDGS 3.5%
Value ($000) $22,082 Shares 488,000 Est. Cost $27.62 Unrealized +52.3%
CNTA CENTESSA PHARMACEUTICALS PLC 3.3%
Value ($000) $21,176 Shares 2,345,075 Est. Cost $7.34 Unrealized —
BBIO BRIDGEBIO PHARMA INC 2.7%
Value ($000) $17,478 Shares 690,000 Est. Cost $30.51 Unrealized -10.4%
INSM INSMED INC 2.6%
Value ($000) $16,750 Shares 250,000 Est. Cost $21.76 Unrealized +78.3%
OCUL OCULAR THERAPEUTIX INC 2.6%
Value ($000) $16,587 Shares 2,425,000 Est. Cost $7.10 Unrealized -13.0%
CATX PERSPECTIVE THERAPEUTICS INC 2.5%
Value ($000) $15,755 Shares 1,580,249 Est. Cost $14.46 Unrealized 0.0%
— MIND MEDICINE MINDMED INC 2.4%
Value ($000) $15,523 Shares 2,153,000 Est. Cost $9.40 Unrealized —
APLS APELLIS PHARMACEUTICALS INC 2.1%
Value ($000) $13,426 Shares 350,000 Est. Cost $47.53 Unrealized -4.7%
PRAX PRAXIS PRECISION MEDICINES I 1.7%
Value ($000) $10,754 Shares 260,000 Est. Cost $44.86 Unrealized +5.3%
TSHA TAYSHA GENE THERAPIES INC 1.6%
Value ($000) $10,242 Shares 4,572,222 Est. Cost $2.36 Unrealized +23.2%
EYPT EYEPOINT PHARMACEUTICALS INC 1.5%
Value ($000) $9,513 Shares 1,093,503 Est. Cost $24.76 Unrealized -43.6%
TERN TERNS PHARMACEUTICALS INC 1.5%
Value ($000) $9,292 Shares 1,364,400 Est. Cost $6.27 Unrealized -3.4%
GOSS GOSSAMER BIO INC 1.3%
Value ($000) $8,277 Shares 9,187,883 Est. Cost $2.93 Unrealized -74.4%
VRDN VIRIDIAN THERAPEUTICS INC 1.3%
Value ($000) $8,066 Shares 620,000 Est. Cost $24.88 Unrealized -44.4%
TNYA TENAYA THERAPEUTICS INC 1.3%
Value ($000) $7,986 Shares 2,576,200 Est. Cost $4.78 Unrealized -13.7%
— REGULUS THERAPEUTICS INC 1.2%
Value ($000) $7,611 Shares 4,263,701 Est. Cost $1.78 Unrealized —
— ALLOVIR INC 1.1%
Value ($000) $7,088 Shares 9,800,000 Est. Cost $0.74 Unrealized —
MLYS MINERALYS THERAPEUTICS INC 1.1%
Value ($000) $7,020 Shares 600,000 Est. Cost $12.37 Unrealized +1.8%
ANTX AN2 THERAPEUTICS INC 1.1%
Value ($000) $6,924 Shares 3,220,263 Est. Cost $4.67 Unrealized -49.1%
— AKERO THERAPEUTICS INC 1.0%
Value ($000) $6,648 Shares 283,372 Est. Cost $25.26 Unrealized —
JSPR JASPER THERAPEUTICS INC 1.0%
Value ($000) $6,526 Shares 287,500 Est. Cost $17.76 Unrealized +35.0%
PEPG PEPGEN INC 0.9%
Value ($000) $6,003 Shares 376,117 Est. Cost $11.81 Unrealized +21.4%
VTYX VENTYX BIOSCIENCES INC 0.9%
Value ($000) $5,523 Shares 2,391,114 Est. Cost $4.42 Unrealized -5.9%
— CYBIN INC 0.8%
Value ($000) $5,042 Shares 18,604,650 Est. Cost $0.41 Unrealized —
IPSC CENTURY THERAPEUTICS INC 0.5%
Value ($000) $3,401 Shares 1,333,650 Est. Cost $3.59 Unrealized -12.1%
— RENEO PHARMACEUTICALS INC 0.5%
Value ($000) $3,398 Shares 2,250,000 Est. Cost $6.46 Unrealized —
SLN SILENCE THERAPEUTICS PLC 0.5%
Value ($000) $3,344 Shares 176,000 Est. Cost $21.60 Unrealized —
BBOT HELIX ACQUISITION CORP II 0.4%
Value ($000) $2,555 Shares 250,000 Est. Cost $10.35 Unrealized -0.6%
— POSEIDA THERAPEUTICS INC 0.3%
Value ($000) $2,149 Shares 736,000 Est. Cost $3.19 Unrealized —
— ELEVATION ONCOLOGY INC 0.3%
Value ($000) $2,017 Shares 747,000 Est. Cost $2.70 Unrealized —
— MERSANA THERAPEUTICS INC 0.3%
Value ($000) $1,994 Shares 992,000 Est. Cost $4.48 Unrealized —
ANNX ANNEXON INC 0.3%
Value ($000) $1,960 Shares 400,000 Est. Cost $4.77 Unrealized +8.4%
FATE FATE THERAPEUTICS INC 0.3%
Value ($000) $1,708 Shares 520,800 Est. Cost $6.19 Unrealized -29.3%
NKTX NKARTA INC 0.2%
Value ($000) $1,418 Shares 240,000 Est. Cost $10.40 Unrealized -32.0%
NUVB NUVATION BIO INC 0.2%
Value ($000) $1,260 Shares 431,600 Est. Cost $1.46 Unrealized +109.0%
— ADICET BIO INC 0.1%
Value ($000) $929 Shares 767,799 Est. Cost $2.35 Unrealized —
— RAPT THERAPEUTICS INC 0.1%
Value ($000) $891 Shares 292,000 Est. Cost $24.85 Unrealized —
— AEROVATE THERAPEUTICS INC 0.1%
Value ($000) $773 Shares 465,440 Est. Cost $25.63 Unrealized —
AUTL AUTOLUS THERAPEUTICS PLC 0.1%
Value ($000) $612 Shares 176,000 Est. Cost $6.38 Unrealized —